1. Home
  2. KLXE vs CUE Comparison

KLXE vs CUE Comparison

Compare KLXE & CUE Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

Logo KLX Energy Services Holdings Inc.

KLXE

KLX Energy Services Holdings Inc.

N/A

Current Price

$1.41

Market Cap

51.1M

Sector

Energy

ML Signal

N/A

Logo Cue Biopharma Inc.

CUE

Cue Biopharma Inc.

N/A

Current Price

$25.25

Market Cap

233.5M

Sector

Health Care

ML Signal

N/A

Company Overview

Basic Information
Metric
KLXE
CUE
Founded
2018
2014
Country
United States
United States
Employees
N/A
N/A
Industry
Oilfield Services/Equipment
Biotechnology: Pharmaceutical Preparations
Sector
Energy
Health Care
Exchange
Nasdaq
Nasdaq
Market Cap
51.1M
233.5M
IPO Year
2018
2017

Fundamental Metrics

Financial Performance
Metric
KLXE
CUE
Price
$1.41
$25.25
Analyst Decision
Strong Buy
Analyst Count
0
3
Target Price
N/A
★ $88.00
AVG Volume (30 Days)
★ 911.8K
353.1K
Earning Date
11-04-2026
11-11-2026
Dividend Yield
N/A
N/A
EPS Growth
N/A
★ 61.11
EPS
★ N/A
N/A
Revenue
★ $636,600,000.00
$27,466,000.00
Revenue This Year
$4.43
N/A
Revenue Next Year
$8.47
N/A
P/E Ratio
N/A
★ N/A
Revenue Growth
N/A
★ 195.75
52 Week Low
$1.35
$0.17
52 Week High
$4.50
$45.50

Technical Indicators

Market Signals
Indicator
KLXE
CUE
Relative Strength Index (RSI) 38.25 42.64
Support Level N/A $23.51
Resistance Level $1.58 $33.11
Average True Range (ATR) 0.09 4.91
MACD 0.01 -0.83
Stochastic Oscillator 25.37 11.41

Price Performance

Historical Comparison
KLXE
CUE

About KLXE KLX Energy Services Holdings Inc.

KLX Energy Services Holdings Inc is a growth-oriented provider of diversified oilfield services to onshore oil and natural gas exploration and production (E&P) companies operating in both conventional and unconventional plays in all of the active basins throughout the United States. It serves the companies engaged in the exploration and development of onshore conventional and unconventional oil and natural gas reserves. Its products and services offerings include surface facilities and equipment, pressure control services, wireline services, fishing services, and engineered products. The company's segments include Southwest; Rocky Mountains and Northeast/Mid-Con region. It derives maximum revenue from Southwest region.

About CUE Cue Biopharma Inc.

Cue Biopharma Inc is a clinical-stage therapeutics company focused on advancing a robust portfolio of potentially transformative therapies aimed at enabling functional cures across immunological disorders. Its product pipeline includes CUE-221, an anti-IgE antibody candidate being developed for allergic diseases. The company has also developed the Immuno-STAT platform for targeting disease-related T cells and is developing CUE-401, an IL-2 and TGF-B therapeutic candidate for autoimmune diseases.

Share on Social Networks: